Valerie Beral Said No Such Thing. The 'Perth Group' Need to Make This More of a Challenge. 22 August 2004
Previous Rapid Response Next Rapid Response Top
Tony Floyd,
Medical Student
Newcastle University

Send response to journal:
Re: Valerie Beral Said No Such Thing. The 'Perth Group' Need to Make This More of a Challenge.

In a 'Perth Group' Response from 20th August 2004 they stated that:

> Once Valerie Beral and her colleagues concluded that HIV plays no role in the development of KS

Following the usual method of:

1. Find a random statement made by altAIDs inc.

2. Check the reference.

3. Discover that the reference does not IN ANY WAY support the statement.

to wit:

"The AIDS epidemic drew attention to KS, a previously rare and little studied condition. The epidemiological evidence summarized here strongly suggests that the disease is caused by a transmissible agent, in addition to HIV" (1)

IN ADDITION to HIV. Not 'no role'. Important difference!

Beral has continued to publish work (2,3,4) that in no way supports the contention that HIV plays 'no role'.

***

References:

(1) Beral V. Epidemiology of Kaposi's sarcoma. Cancer Surv. 1991;10:5-22. Review. Erratum in: Cancer Surv 1992;12:following 225.

(2) Ziegler J, Newton R, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C; Uganda Kaposi's Sarcoma Study Group. Risk factors for Kaposi's sarcoma: a case-control study of HIV-seronegative people in Uganda. Int J Cancer. 2003 Jan 10;103(2):233-40.

(3) Newton R, Ziegler J, Bourboulia D, Casabonne D, Beral V, Mbidde E, Carpenter L, Reeves G, Parkin DM, Wabinga H, Mbulaiteye S, Jaffe H, Weiss R, Boshoff C; Uganda Kaposi's Sarcoma Study Group. The sero-epidemiology of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in adults with cancer in Uganda. Int J Cancer. 2003 Jan 10;103(2):226-32.

(4) Babiker A, Darbyshire J, Pezzotti P, Porter K, Rezza G, Walker SA, Beral V, Coutinho R, Del Amo J, Gill N, Lee C, Meyer L, Tyrer F, Dabis F, Thiebaut R, Lawson-Aye S, Boufassa F, Hamouda O, Fischer K, Pezzotti P, Rezza G, Touloumi G, Hatzakis A, Karafoulidou A, Katsarou O, Brettle R, del Romero J, Prins M, van Benthem B, Kirk O, Pederson C, Hernandez Aguado I, Perez-Hoyos S, Eskild A, Bruun JN, Sannes M, Sabin C, Lee C, Johnson AM, Phillips AN, Francioli P, Vanhems P, Egger M, Rickenbach M, Cooper D, Kaldor J, Ashton L, Vizzard J, Muga R, Day NE, De Angelis D; CASCADE Collaboration. Changes over calendar time in the risk of specific first AIDS-defining events following HIV seroconversion, adjusting for competing risks. Int J Epidemiol. 2002 Oct;31(5):951-8.

Competing interests: None declared